Stockscreener 앱 받기
3.26
1.81%
-0.06
시간 외 거래:
3.32
0.06
+1.84%
Aclarion Inc 주식(ACON)의 최신 뉴스
Aclarion Adopts One-Year Stockholder Rights Protection Plan - TipRanks
Aclarion (NASDAQ: ACON) sets 10% trigger in one-year rights plan - Stock Titan
Aclarion adopts one-year stockholder rights plan - Investing.com
Aclarion installs 1-year takeover defense, keeps door open to fair bids - Stock Titan
Aclarion, Inc. Pursues Insurance Reimbursement Initiatives and Reports Strong Momentum Leading into 2026 - Quiver Quantitative
Aclarion Publishes CEO Shareholder Letter Highlighting Strategic Progress and 2026 Catalysts - Bluefield Daily Telegraph
Aclarion targets US insurers as back-pain trial readout nears - Stock Titan
Aclarion : Shareholder Letter from Chief Executive Officer Brent Ness - marketscreener.com
Aclarion, Inc. Revolutionizes Low Back Pain Diagnosis with MR Spectroscopy and AI-Powered NOCISCAN Platform 798083 - Minichart
Published on: 2026-03-19 07:53:44 - baoquankhu1.vn
Aclarion (NASDAQ: ACON) expands NOCISCAN spine diagnostics and AI plans - Stock Titan
Aclarion 10-K: Revenue $0.076M, EPS (13.61) — Annual Report Highlights - TradingView
ACON: Revenue up 65.6% to $75.7K; net loss $7.2M; $22.6M raised in 2025, $10.4M in 2026 - TradingView
Published on: 2026-03-19 06:54:42 - baoquankhu1.vn
Aclarion to Present at ROTH Conference, Showcasing Nociscan Technology for Chronic Back Pain Diagnosis - citybuzz -
Is Aclarion Inc Equity Warrant still a buy after recent gainsQuarterly Profit Report & Safe Entry Trade Reports - baoquankhu1.vn
Aclarion, Inc. to Engage with Investors at the 38th Annual ROTH Conference Regarding Nociscan Advancements - Quiver Quantitative
Aclarion to Participate in the 38th Annual ROTH Conference, Highlighting Key 2026 Catalysts and Strong Balance Sheet - Bitget
Back pain scan firm Aclarion meets investors at ROTH with no debt - Stock Titan
Investment Review: Whats the outlook for Aclarion Inc Equity Warrants sectorWeekly Market Summary & Daily Technical Stock Forecast Reports - baoquankhu1.vn
Aug Shorts: Is Aclarion Inc Equity Warrant benefiting from interest rate changes2026 Technical Overview & Consistent Profit Alerts - baoquankhu1.vn
Aclarion CEO to Present AI-Powered Back Pain Diagnostic Technology at Leading MedTech Conference - citybuzz -
Aclarion CEO Brent Ness to Attend LSI USA 2026 - Bitget
Aclarion, Inc. CEO Brent Ness to Attend LSI USA 2026 to Discuss NOCISCAN and Industry Partnerships - Quiver Quantitative
Quarterly Risk: Is Aclarion Inc Equity Warrant stock undervalued right nowQuarterly Profit Review & Free High Accuracy Swing Entry Alerts - baoquankhu1.vn
Decliners Report: Is Aclarion Inc Equity Warrant attractive for institutional investorsTrade Volume Report & Growth-Oriented Investment Plans - baoquankhu1.vn
What is Aclarion Inc Equity Warrants 5 year growth outlookJuly 2025 Spike Watch & High Accuracy Swing Entry Alerts - baoquankhu1.vn
Will Aclarion Inc. stock benefit from upcoming earnings reports2026 Chart Watch & Proven Capital Preservation Methods - Naître et grandir
Aug EndMonth: How Aclarion Inc. Equity Warrant stock reacts to job market dataTrade Analysis Report & Accurate Buy Signal Notifications - Naître et grandir
Dividend Watch: Will Aclarion Inc Equity Warrant outperform during market rallies2025 Analyst Calls & Breakout Confirmation Alerts - baoquankhu1.vn
Analyst Calls: Will Aclarion Inc Equity Warrant outperform during market ralliesIndex Update & Consistent Return Strategy Ideas - baoquankhu1.vn
Bank Watch: Does Five Below Inc stock have upside surprise potentialMarket Activity Recap & Safe Entry Momentum Tips - baoquankhu1.vn
Retail Trends: Whats next for CalciMedica Inc stock2025 Sector Review & Technical Entry and Exit Tips - baoquankhu1.vn
ACON PE Ratio & Valuation, Is ACON Overvalued - Intellectia AI
Activity Recap: Is Tidewater Inc forming a breakout patternWeekly Market Outlook & Weekly Top Stock Performers List - baoquankhu1.vn
ACON Financials: Income Statement, Balance Sheet & Cash Flow - Stock Titan
Volatility Watch: Is Aclarion Inc still a buy after recent gainsTrade Risk Summary & High Return Stock Watch Alerts - baoquankhu1.vn
Trading Recap: Whats the outlook for Aclarion Inc Equity Warrants sectorJuly 2025 Summary & Fast Exit/Entry Strategy Plans - baoquankhu1.vn
Investor Mood: Is Aclarion Inc Equity Warrant still a buy after recent gains - baoquankhu1.vn
Market Wrap: Is Aclarion Inc Equity Warrant stock undervalued right now2025 Big Picture & Reliable Entry Point Trade Alerts - baoquankhu1.vn
Can Aclarion Inc. Equity Warrant stock continue upward trend2025 Key Lessons & Safe Entry Momentum Stock Tips - mfd.ru
US Market Wrap: Should I hold or sell Aclarion Inc. Equity Warrant now2025 Short Interest & Stepwise Entry and Exit Trade Signals - mfd.ru
Is Aclarion Inc. stock positioned for long term growthWeekly Earnings Recap & Consistent Income Trade Ideas - mfd.ru
ACON Earning Date, Earning Analysis and Earning Prediction - Intellectia AI
ACON Financials: Revenue Breakdown, Margins & Competitor Comparison - Intellectia AI
Can Aclarion Inc. weather a recessionNew Guidance & Verified Stock Trade Ideas - mfd.ru
What are Aclarion Inc.’s earnings expectationsWeekly Stock Report & Reliable Price Action Trade Plans - mfd.ru
Earnings Beat: Is TriSalus Life Sciences Inc Equity Warrant a strong growth stock2025 Growth vs Value & Short-Term Trading Alerts - baoquankhu1.vn
What’s the outlook for Aclarion Inc. Equity Warrant’s sectorWeekly Investment Report & Low Drawdown Trading Strategies - mfd.ru
NeuroOne Medical Technologies (NASDAQ:NMTC) versus Aclarion (NASDAQ:ACON) Head to Head Contrast - Defense World
How does Aclarion Inc. Equity Warrant correlate with NasdaqWeekly Investment Summary & Daily Chart Pattern Signals - mfd.ru
How does Aclarion Inc. compare to its peersInsider Selling & Precise Trade Entry Recommendations - mfd.ru
Market Leaders: Whats the outlook for Aclarion Inc Equity Warrants sectorWeekly Profit Report & Short-Term High Return Ideas - baoquankhu1.vn
Analyst Upgrade: Does SPOT have declining or rising EPSOil Prices & Community Trade Idea Sharing - baoquankhu1.vn
Aclarion secures $10.4M for back-pain diagnostic technology - BizWest
Aclarion Publishes 2026 Shareholder Letter from the Chairman - The Globe and Mail
Aclarion, Inc. Announces Strong Financial Position and Path to CLARITY Trial Milestones Ahead of 2026 - Quiver Quantitative
No new funding planned as Aclarion awaits back pain trial data in 2026 - Stock Titan
EXCLUSIVE: Aclarion CEO Looks To Bigger AI MedTech’s Playbook To Reverse Fortunes - Asianet Newsable
Aclarion CEO Outlines 2026 Execution Plan Focused on Reimbursement and Adoption - intellectia.ai
Aclarion CEO Bets On Bigger AI MedTech’s Playbook To Revive Sagging Stock - Stocktwits
Aclarion partners with Source Healthcare to expand Nociscan availability By Investing.com - Investing.com Nigeria
Aclarion Adds High-Volume Practice, Source Healthcare, to Support Nociscan Growth and Real-World Evidence Generation - Ortho Spine News
5.94%
자본화:
|
볼륨(24시간):